Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119846
Chunk: 167

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 167
---
JA expire at the end of 2025 or are modified beginning in 2026. The U.S. Congress and the current administration have indicated that they intend to pursue legislation in 2025 to make permanent the 2017 TCJA provisions but there is no guarantee
that this initiative will be successful. Future changes in tax laws could have a material adverse effect on our business, cash flow, financial condition or results of operations. The impact of these tax reforms on holders of our Common Stock is
uncertain and could be adverse. We urge our stockholders to consult with their legal and tax advisors with respect to such legislation and the potential tax consequences of investing in our Common Stock.

Our Warrants are exercisable for our Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.

As of March 31, 2025, we have 6,958,309 SPAC Warrants outstanding, which are currently
exercisable for an aggregate of up to 198,810 shares of our Common Stock in accordance with the terms of the Warrant Agreement, dated as of January 6, 2021, between Continental, as warrant agent, and Vickers, governing those securities. The
exercise price of these SPAC Warrants is $402.50 per whole share.

As of March 31, 2025, (i) outstanding Penny Warrants to purchase
an aggregate of 6,500,000 shares of our Common Stock are exercisable under the terms thereof, the exercise price of which is $0.01 per share, (ii) outstanding February 2024 BDO Firm Warrants (as defined below) to purchase an aggregate of
108,686 shares of our Common Stock are exercisable under the terms thereof, the exercise price of which is $59.50 per share; (iii) outstanding February 2024 BDO Representative Warrants (as defined below) to purchase an aggregate of 13,446
shares of our Common Stock are exercisable under the terms thereof, the exercise price of which is $74.38 per share; (iv) outstanding Deposit Warrant (as defined below) to purchase an aggregate of 3,250,000 shares of our Common Stock are
exercisable under the terms thereof, the exercise price of which is $1.20 per share, (v) outstanding April 2024 RDO Common Warrants (as defined below) to purchase an aggregate of